Literature DB >> 27066895

The intersection of cell death and inflammasome activation.

James E Vince1,2, John Silke3,4.   

Abstract

Inflammasomes sense cellular danger to activate the cysteine-aspartic protease caspase-1, which processes precursor interleukin-1β (IL-1β) and IL-18 into their mature bioactive fragments. In addition, activated caspase-1 or the related inflammatory caspase, caspase-11, can cleave gasdermin D to induce a lytic cell death, termed pyroptosis. The intertwining of IL-1β activation and cell death is further highlighted by research showing that the extrinsic apoptotic caspase, caspase-8, may, like caspase-1, directly process IL-1β, activate the NLRP3 inflammasome itself, or bind to inflammasome complexes to induce apoptotic cell death. Similarly, RIPK3- and MLKL-dependent necroptotic signaling can activate the NLRP3 inflammasome to drive IL-1β inflammatory responses in vivo. Here, we review the mechanisms by which cell death signaling activates inflammasomes to initiate IL-1β-driven inflammation, and highlight the clinical relevance of these findings to heritable autoinflammatory diseases. We also discuss whether the act of cell death can be separated from IL-1β secretion and evaluate studies suggesting that several cell death regulatory proteins can directly interact with, and modulate the function of, inflammasome and IL-1β containing protein complexes.

Entities:  

Keywords:  Apoptosis; Caspase-1; Caspase-8; Inflammasome; MLKL; Necroptosis; Pyroptosis; RIPK3

Mesh:

Substances:

Year:  2016        PMID: 27066895     DOI: 10.1007/s00018-016-2205-2

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  161 in total

1.  Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1β.

Authors:  Nicolas Dupont; Shanya Jiang; Manohar Pilli; Wojciech Ornatowski; Dhruva Bhattacharya; Vojo Deretic
Journal:  EMBO J       Date:  2011-11-08       Impact factor: 11.598

2.  MAVS Promotes Inflammasome Activation by Targeting ASC for K63-Linked Ubiquitination via the E3 Ligase TRAF3.

Authors:  Kai Guan; Congwen Wei; Zirui Zheng; Ting Song; Feixiang Wu; Yanhong Zhang; Ye Cao; Shengli Ma; Wei Chen; Quanbin Xu; Weiwei Xia; Jun Gu; Xiang He; Hui Zhong
Journal:  J Immunol       Date:  2015-04-06       Impact factor: 5.422

3.  Inflammasome-independent IL-1β mediates autoinflammatory disease in Pstpip2-deficient mice.

Authors:  Suzanne L Cassel; John R Janczy; Xinyu Bing; Shruti P Wilson; Alicia K Olivier; Jesse E Otero; Yoichiro Iwakura; Dmitry M Shayakhmetov; Alexander G Bassuk; Yousef Abu-Amer; Kim A Brogden; Trudy L Burns; Fayyaz S Sutterwala; Polly J Ferguson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-06       Impact factor: 11.205

4.  Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes.

Authors:  Seth L Masters; Aisling Dunne; Shoba L Subramanian; Rebecca L Hull; Gillian M Tannahill; Fiona A Sharp; Christine Becker; Luigi Franchi; Eiji Yoshihara; Zhe Chen; Niamh Mullooly; Lisa A Mielke; James Harris; Rebecca C Coll; Kingston H G Mills; K Hun Mok; Philip Newsholme; Gabriel Nuñez; Junji Yodoi; Steven E Kahn; Ed C Lavelle; Luke A J O'Neill
Journal:  Nat Immunol       Date:  2010-09-12       Impact factor: 25.606

5.  The Inflammatory Caspases-1 and -11 Mediate the Pathogenesis of Dermatitis in Sharpin-Deficient Mice.

Authors:  Todd Douglas; Claudia Champagne; Alexandre Morizot; Jean-Martin Lapointe; Maya Saleh
Journal:  J Immunol       Date:  2015-07-27       Impact factor: 5.422

6.  Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production.

Authors:  Tatsuya Saitoh; Naonobu Fujita; Myoung Ho Jang; Satoshi Uematsu; Bo-Gie Yang; Takashi Satoh; Hiroko Omori; Takeshi Noda; Naoki Yamamoto; Masaaki Komatsu; Keiji Tanaka; Taro Kawai; Tohru Tsujimura; Osamu Takeuchi; Tamotsu Yoshimori; Shizuo Akira
Journal:  Nature       Date:  2008-10-05       Impact factor: 49.962

7.  A TNFSF15 disease-risk polymorphism increases pattern-recognition receptor-induced signaling through caspase-8-induced IL-1.

Authors:  Matija Hedl; Clara Abraham
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-02       Impact factor: 11.205

Review 8.  Critical functions of priming and lysosomal damage for NLRP3 activation.

Authors:  Veit Hornung; Eicke Latz
Journal:  Eur J Immunol       Date:  2010-03       Impact factor: 5.532

9.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.

Authors:  Jorge Henao-Mejia; Eran Elinav; Chengcheng Jin; Liming Hao; Wajahat Z Mehal; Till Strowig; Christoph A Thaiss; Andrew L Kau; Stephanie C Eisenbarth; Michael J Jurczak; Joao-Paulo Camporez; Gerald I Shulman; Jeffrey I Gordon; Hal M Hoffman; Richard A Flavell
Journal:  Nature       Date:  2012-02-01       Impact factor: 49.962

10.  ER stress activates the NLRP3 inflammasome via an UPR-independent pathway.

Authors:  P Menu; A Mayor; R Zhou; A Tardivel; H Ichijo; K Mori; J Tschopp
Journal:  Cell Death Dis       Date:  2012-01-26       Impact factor: 8.469

View more
  63 in total

Review 1.  Reversal of fortune: estrogen receptor-β in endometriosis.

Authors:  Rosalia C M Simmen; Angela S Kelley
Journal:  J Mol Endocrinol       Date:  2016-06-07       Impact factor: 5.098

2.  Extracellular DNA, Neutrophil Extracellular Traps, and Inflammasome Activation in Severe Asthma.

Authors:  Marrah E Lachowicz-Scroggins; Eleanor M Dunican; Annabelle R Charbit; Wilfred Raymond; Mark R Looney; Michael C Peters; Erin D Gordon; Prescott G Woodruff; Emma Lefrançais; Brenda R Phillips; David T Mauger; Suzy A Comhair; Serpil C Erzurum; Mats W Johansson; Nizar N Jarjour; Andrea M Coverstone; Mario Castro; Annette T Hastie; Eugene R Bleecker; Merritt L Fajt; Sally E Wenzel; Elliot Israel; Bruce D Levy; John V Fahy
Journal:  Am J Respir Crit Care Med       Date:  2019-05-01       Impact factor: 21.405

3.  MLKL Activation Triggers NLRP3-Mediated Processing and Release of IL-1β Independently of Gasdermin-D.

Authors:  Kimberley D Gutierrez; Michael A Davis; Brian P Daniels; Tayla M Olsen; Pooja Ralli-Jain; Stephen W G Tait; Michael Gale; Andrew Oberst
Journal:  J Immunol       Date:  2017-01-27       Impact factor: 5.422

4.  MLN4924 suppresses lipopolysaccharide-induced proinflammatory cytokine production in neutrophils in a dose-dependent manner.

Authors:  Jiayang Jin; Zhaofei Jing; Zhenjie Ye; Lu Guo; Lei Hua; Qingyang Wang; Jing Wang; Qianqian Cheng; Jiyan Zhang; Yunlu Xu; Lin Wei
Journal:  Oncol Lett       Date:  2018-03-23       Impact factor: 2.967

Review 5.  Staphylococcus aureus pore-forming toxins: The interface of pathogen and host complexity.

Authors:  E Sachiko Seilie; Juliane Bubeck Wardenburg
Journal:  Semin Cell Dev Biol       Date:  2017-04-23       Impact factor: 7.727

6.  Protective effect of exogenous hydrogen sulfide on diaphragm muscle fibrosis in streptozotocin-induced diabetic rats.

Authors:  Rui Yang; Qiang Jia; Yan Li; Shomaila Mehmood
Journal:  Exp Biol Med (Maywood)       Date:  2020-06-03

7.  Cell death is not essential for caspase-1-mediated interleukin-1β activation and secretion.

Authors:  S A Conos; K E Lawlor; D L Vaux; J E Vince; L M Lindqvist
Journal:  Cell Death Differ       Date:  2016-07-15       Impact factor: 15.828

8.  Small-Volume Adenosine, Lidocaine, and Mg2+ 4-Hour Infusion Leads to 88% Survival after 6 Days of Experimental Sepsis in the Rat without Antibiotics.

Authors:  Maddison Jade Griffin; Hayley Louise Letson; Geoffrey Phillip Dobson
Journal:  Clin Vaccine Immunol       Date:  2016-11-04

9.  NLRP3 Is a Critical Regulator of Inflammation and Innate Immune Cell Response during Mycoplasma pneumoniae Infection.

Authors:  Jesus A Segovia; Te-Hung Chang; Vicki T Winter; Jacqueline J Coalson; Marianna P Cagle; Lavanya Pandranki; Santanu Bose; Joel B Baseman; Thirumalai R Kannan
Journal:  Infect Immun       Date:  2017-12-19       Impact factor: 3.441

10.  TLR4 in skin cancer: From molecular mechanisms to clinical interventions.

Authors:  Sally E Dickinson; Georg T Wondrak
Journal:  Mol Carcinog       Date:  2019-04-24       Impact factor: 4.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.